In brief
| Vitamin D and the thyroid | |
|---|---|
| Who it matters to | Autoimmune thyroiditis, hypothyroidism, deficiency on a blood test |
| What it does | Calms an over-active immune response |
| What the work shows | Lower thyroid antibodies, fewer new autoimmune diseases |
| What it does not do | Replace thyroxine or remove the need for follow-up |
| The main rule | Dose by blood test, not «one big ampoule once a year» |
Why it belongs in a thyroid conversation
Vitamin D is not really a vitamin. By its structure it is a hormone, and receptors for it sit in almost every tissue, including immune cells and the thyroid gland itself.
In autoimmune thyroiditis the immune system makes a mistake: it attacks the gland’s own tissue. Vitamin D acts here as a volume control — it does not switch the immune system off, it quietens the excessive, destructive part of the response and supports the part that keeps the body from attacking itself.
Hence the practical interest: if someone with thyroiditis also has vitamin D deficiency — and that is common — then correcting it works on the substance of the disease, not merely «on the bones».
What the studies say
Antibodies. A meta-analysis of 12 studies (862 people with Hashimoto’s thyroiditis) found that vitamin D lowers antibodies to thyroid peroxidase and thyroglobulin, slightly lowers TSH and raises free T3 and T4. The effect was clearer with courses longer than 12 weeks — short ones do not have time to show themselves.
Prevention. The largest trial in this area is VITAL: 25,871 participants followed for more than five years. Those taking vitamin D developed autoimmune diseases 22% less often than those on placebo. That covers autoimmune disease broadly rather than the thyroid alone, but the direction is the same.
The link with deficiency. A separate analysis confirmed what practice suggests: people with autoimmune thyroid disease have lower vitamin D on average, and deficiency among them is more common.
Injection or capsules
Injectable forms such as Dibase 300,000 IU exist for a reason, but their place is narrower than people assume.
| Capsules and drops | Injection | |
|---|---|---|
| When it fits | Most situations | Impaired absorption, forgetfulness, very low starting level |
| How it behaves | A steady level with daily intake | A sharp rise, then a slow decline |
| Control | The dose is easy to adjust | What is given cannot be taken back |
| Follow-up | Blood test in 8–12 weeks | Blood test in 8–12 weeks |
Situations where an injection is genuinely justified: bowel disease with impaired absorption, states after stomach surgery, severe deficiency needing a quick start, and cases where a person genuinely cannot take something every day.
A warning about one big dose a year
This is the section worth reading to the end.
The appeal is obvious: one injection and you forget about it for a year. But that is exactly the schedule tested in 2,256 older women: 500,000 IU once a year. The result went against expectation — the vitamin D group had 15% more falls and 26% more fractures than placebo. Falls rose especially in the first three months after the dose.
The practical conclusion is simple: sharp peaks do the body no good. Smaller doses more often are wiser — daily, or, if it is an injection, split and guided by blood tests, rather than one ampoule «for the whole year».
How it is done properly
1. A blood test first
25(OH)D. Without it the dose is guesswork: one person has a deep deficiency, another none at all.
2. The dose follows the result
It depends on the starting level, body weight and the cause of the deficiency. There is no universal «thyroid dose».
3. Recheck at 8–12 weeks
A repeat test shows whether the target was reached. In thyroiditis, antibodies and TSH are watched alongside it.
4. Maintenance, not a course
Deficiency returns once the correction stops. The maintenance dose is set by repeat testing.
5. Not on its own
Vitamin D affects calcium handling, so vitamin K2 and magnesium usually come up beside it — there is a separate guide on that pair.
Who it is not for
▸ With raised blood calcium — vitamin D will push it higher.
▸ In sarcoidosis, tuberculosis and other granulomatous disease — vitamin D is processed differently there and ordinary doses are hazardous.
▸ In severe kidney disease — the form and dose are chosen separately.
▸ With a history of kidney stones — only with calcium monitoring.
▸ High doses without a blood test — for anyone.
The short version
▸ Vitamin D is a hormone, and in autoimmune thyroiditis it works on the substance of the process, not only on bone.
▸ Antibodies fall, but over courses longer than three months, not in a fortnight.
▸ It does not replace thyroxine. If the gland can no longer cope, the hormone is needed regardless.
▸ Injection is for particular cases: impaired absorption, severe deficiency, an impossible daily routine.
▸ A mega-dose once a year is a bad idea — in trial it produced more falls and fractures.
▸ Everything starts with a 25(OH)D test and is checked by the same test at 8–12 weeks.
On choosing a dose. What you need, in what form and how often to check, is worked out in consultation — from your blood tests and your thyroid. High doses are not prescribed blind.
Sources
1. Tang J, et al. Effects of vitamin D supplementation on autoantibodies and thyroid function in patients with Hashimoto's thyroiditis: a meta-analysis. Medicine (Baltimore). 2023;102(52):e36759. PMID 38206745
2. Hahn J, et al. Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. BMJ. 2022;376:e066452. PMID 35082139
3. Jiang H, et al. Effects of vitamin D treatment on thyroid function and autoimmunity markers in patients with Hashimoto's thyroiditis: a meta-analysis of randomized controlled trials. J Clin Pharm Ther. 2022;47(6):767–775. PMID 34981556
4. Wang J, et al. Meta-analysis of the association between vitamin D and autoimmune thyroid disease. Nutrients. 2015;7(4):2485–2498. PMID 25854833
5. Sanders KM, et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA. 2010;303(18):1815–1822. PMID 20460620
